Comparison of nintedanib-induced gastrointestinal adverse events in patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias

被引：0
|
作者：
Imai, Miyu [1 ]
Okabayashi, Hiroko [1 ]
Akaike, Kimitaka [1 ]
Hamada, Shohei [1 ]
Masunaga, Aiko [1 ]
Ichiyasu, Hidenori [1 ]
Sakagami, Takuro [1 ]
机构：
[1] Kumamoto Univ Hosp, Resp Med, Kumamoto, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP16-506
引用
收藏
页码：408 / 409
页数：2
相关论文
共 50 条
  • [1] Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias
    Imai, Miyu
    Okabayashi, Hiroko
    Akaike, Kimitaka
    Hamada, Shohei
    Masunaga, Aiko
    Ichiyasu, Hidenori
    Sakagami, Takuro
    RESPIRATORY INVESTIGATION, 2024, 62 (03) : 317 - 321
  • [2] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Distler, Oliver
    Highland, Kristin B.
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen D.
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Tetzlaff, Kay
    Kuwana, Masataka
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26): : 2518 - 2528
  • [3] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Andreasson, Kristofer
    Wuttge, Dirk M.
    Wollheim, Frank A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1595 - 1596
  • [4] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E755 - E755
  • [5] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Rahimi, Susan
    LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 136 - 136
  • [6] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
    Distler, Oliver
    Gahlemann, Martina
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
  • [7] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [8] SAFETY PROFILE OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Highland, Kristin
    Distler, Oliver
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Kohlbrenner, Veronika
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Kuwana, Masataka
    Maher, Toby M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 200 - 200
  • [9] GASTROINTESTINAL ADVERSE EVENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) TREATED WITH NINTEDANIB: DATA FROM THE SENSCIS TRIAL
    Maher, Toby
    Highland, Kristin
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Kohlbrenner, Veronika
    Kuwana, Masataka
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 831 - 832
  • [10] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
12345